Filed: 5/15/2025ACC: 0000950123-25-005578
π What this filing means
ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD filed this quarterly 13FβHR report disclosing 4 equity positions with a total reported market value of $38.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$38.32M
Total AUM (reported)
3.49M
Total Shares
Allocation by class
COM$33.44M87.3%
CLASS A COM$4.88M12.7%
Portfolio Concentration
Top 3$37.92M98.9%
4β10$405.2K1.1%
Top 3 weight
98.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 3.49M
Sole
Full voting authority
3.49M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings4
Rows:
CERIBELL INC
SOLEShares1.09M
TypeSH
Market value$20.90M
54.54%
Sole
1.09M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares495.53K
TypeSH
Market value$12.14M
31.67%
Sole
495.53K
Shared
0.00
None
0.00
RAPID MICRO BIOSYSTEMS INC
SOLEShares1.85M
TypeSH
Market value$4.88M
12.73%
Sole
1.85M
Shared
0.00
None
0.00
PULMONX CORP
SOLEShares60.20K
TypeSH
Market value$405.2K
1.06%
Sole
60.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CERIBELL INCSOLE | COM | 1.09M | SH | $20.90M 54.54% | 1.09M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 495.53K | SH | $12.14M 31.67% | 495.53K | 0.00 | 0.00 |
RAPID MICRO BIOSYSTEMS INCSOLE | CLASS A COM | 1.85M | SH | $4.88M 12.73% | 1.85M | 0.00 | 0.00 |
PULMONX CORPSOLE | COM | 60.20K | SH | $405.2K 1.06% | 60.20K | 0.00 | 0.00 |